Delaying Hair Loss: A Benchmark in Dermatology’s Resurgence
Absci Anticipates 13-Week Data on ABS-201 Amidst Dermatology Sector Rebound Berlin, Germany – May 1, 2026 – Biotechnology company Absci is preparing to release 13-week data for its lead program, ABS-201, as the dermatology sector experiences a resurgence driven by advancements in treating conditions like alopecia. The anticipated data release comes as investors closely watch … Read more